Wait, we have a special offer for you! ✋

Get your exclusive discount now

Use FY25SAVE to get flat 20% off on the report No, I'd pay the full price

Terms & Conditions : This coupon is vaild exclusively for Global Market Reports 2025 and can be used Until March 31 , 2025 .

Global Tepezza Market Report 2025

Tepezza Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Clinical Indication (Thyroid Eye Disease (TED), Orbital Inflammatory Diseases, Inflammatory Ocular Conditions), By Route Of Administration (Intravenous, Subcutaneous), By Distribution Channel (Hospital Pharmacies, Online Pharmacies), By End User (Adult, Geriatric)

Tepezza Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Tepezza Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

What Is Covered Under Tepezza Market?

Tepezza refers to a prescription medication containing teprotumumab-trbw, a monoclonal antibody designed to target and inhibit the activity of insulin-like growth factor-1 receptor (IGF-1R). It is used for the treatment of thyroid eye disease (TED), a rare autoimmune condition that affects the muscles and tissues around the eyes, causing inflammation, swelling, and vision problems.

The main types of clinical indications in tepezza are thyroid eye disease (TED), orbital inflammatory diseases, and inflammatory ocular conditions. Thyroid eye disease (TED) is an autoimmune condition in which inflammation of the tissues around the eyes occurs, often linked to thyroid disorders. It can be administered through both intravenous and subcutaneous routes and distributed through various channels such as hospital pharmacies and online pharmacies. The various end users include adults and geriatrics.

What Is The Tepezza Market Size 2025 And Growth Rate?

The tepezza market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the increasing prevalence of thyroid eye disease, approval by the FDA for TED treatment, limited treatment options for TED, high unmet need for effective therapies, advancement in biologic drug development, and growing awareness and diagnosis of TED.

What Is The Tepezza Market Growth Forecast?

The tepezza market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to a growing aging population, expansion into new geographical markets, increasing incidence of thyroid diseases, advancements in personalized medicine, and growing adoption of biologic therapies. Major trends in the forecast period include a shift towards home-based care, development of alternative administration methods, rise in combination therapies for TED, increasing focus on precision medicine, and integration of AI in treatment planning.

Tepezza Market Size and growth rate 2025 to 2029: Graph

How Is The Tepezza Market Segmented?

The tepezza market covered in this report is segmented –

1) By Clinical Indication: Thyroid Eye Disease (TED); Orbital Inflammatory Diseases; Inflammatory Ocular Conditions

2) By Route Of Administration: Intravenous; Subcutaneous

3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies

4) By End User: Adult; Geriatric

Book your 30 minutes free consultation with our research experts

Contact Us

What Is Driving The Tepezza Market? Increasing Incidence Of Thyroid Diseases Driving Market Growth

Increasing incidence of thyroid diseases is expected to propel the growth of the tepezza market going forward. Thyroid diseases refer to a range of conditions that affect the structure or function of the thyroid gland, a butterfly-shaped gland located in the neck. The incidence of thyroid diseases is increasing due to several factors, including improved diagnostic techniques such as high-resolution ultrasound and fine-needle aspiration, which detect thyroid abnormalities earlier. Tepezza (teprotumumab) is used to treat thyroid eye disease by inhibiting the insulin-like growth factor-1 receptor (IGF-1R), reducing inflammation, swelling, and proptosis around the eyes. For instance, in July 2022, according to the National Institutes of Health, a US-based government agency, in the United States, thyroid cancer was projected to be the 13th most commonly diagnosed cancer in 2022, representing approximately 44,000 new cases, or 2.3% of all cancer diagnoses. Therefore, increasing incidence of thyroid diseases is driving the growth of the tepezza market.

Who Are The Major Players In The Global Tepezza Market?

Major companies operating in the tepezza market are Amgen Inc.

What Are The Key Trends Of The Global Tepezza Market? Regulatory Advancements Expand Tepezza’s Accessibility And Impact In Thyroid Eye Disease

The key trend in the tepezza (teprotumumab-trbw) market is obtaining regulatory approvals to expand its indications beyond Thyroid Eye Disease (TED). Regulatory approvals refer to formal authorizations from health agencies ensuring a drug's safety, efficacy, and quality for specific medical uses. For instance, in April 2023, Horizon Therapeutics plc, an Ireland-based biotechnology company, announced that the FDA has approved an update to the indication language for TEPEZZA (teprotumumab-trbw), allowing its use in patients with Thyroid Eye Disease (TED) regardless of disease activity or duration. This significant change enhances access to treatment for all eligible TED patients, as TEPEZZA is the first and only FDA-approved medication specifically for this condition. The approval is supported by data from a Phase 4 clinical trial demonstrating TEPEZZA's efficacy in reducing eye bulging in patients with long-standing TED. Horizon's CEO, Tim Walbert, highlighted that this update aims to improve timely access to therapy, ultimately benefiting patient outcomes.

What Are Latest Mergers And Acquisitions In The Tepezza Market? Amgen Acquires Horizon Therapeutics To Expand Rare Disease Portfolio

In October 2023, Amgen Inc., a US-based biotechnology company, acquired Horizon Therapeutics plc. for $27.8 billion. With this acquisition, Amgen aims to strengthen its position as a leader in the treatment of rare and inflammatory diseases by incorporating Horizon Therapeutics' portfolio, which includes Tepezza for thyroid eye disease, Krystexxa for chronic gout, and Uplizna for autoimmune conditions, expanding its offerings in critical therapeutic areas and accelerating its growth in the inflammation space. Horizon Therapeutics plc is a US-based pharmaceutical company that offers Tepezza, which is a treatment specifically designed for thyroid eye disease (TED).

Regional Analysis For The Global Tepezza Market

North America was the largest region in the tepezza market in 2024. The regions covered in the tepezza market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tepezza market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Tepezza Market?

The tepezza market consists of sales of pre-filled syringes, pen devices, and lyophilized powders for reconstitution. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Tepezza Industry?

The tepezza market research report is one of a series of new reports from The Business Research Company that provides tepezza market statistics, including tepezza industry global market size, regional shares, competitors with a tepezza market share, detailed tepezza market segments, market trends and opportunities, and any further data you may need to thrive in the tepezza industry. This Tepezza market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Tepezza Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The tepezza market covered in this report is segmented –
1) By Clinical Indication: Thyroid Eye Disease (TED); Orbital Inflammatory Diseases; Inflammatory Ocular Conditions
2) By Route Of Administration: Intravenous; Subcutaneous
3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies
4) By End User: Adult; Geriatric
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Amgen Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Tepezza Market Characteristics

    3. Tepezza Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Tepezza Market Trends And Strategies

    5. Tepezza Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Tepezza Growth Analysis And Strategic Analysis Framework

    6.1. Global Tepezza PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Tepezza Market Growth Rate Analysis

    6.4. Global Tepezza Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Tepezza Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Tepezza Total Addressable Market (TAM)

    7. Global Tepezza Pricing Analysis & Forecasts

    8. Tepezza Market Segmentation

    8.1. Global Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Thyroid Eye Disease (TED)

    Orbital Inflammatory Diseases

    Inflammatory Ocular Conditions

    8.2. Global Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Intravenous

    Subcutaneous

    8.3. Global Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospital Pharmacies

    Online Pharmacies

    8.4. Global Tepezza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Adult

    Geriatric

    9. Global Tepezza Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Tepezza Market Regional And Country Analysis

    10.1. Global Tepezza Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Tepezza Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Tepezza Market

    11.1. Asia-Pacific Tepezza Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Tepezza Market

    12.1. China Tepezza Market Overview

    12.2. China Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Tepezza Market

    13.1. India Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Tepezza Market

    14.1. Japan Tepezza Market Overview

    14.2. Japan Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Tepezza Market

    15.1. Australia Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Tepezza Market

    16.1. South Korea Tepezza Market Overview

    16.2. South Korea Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Tepezza Market

    17.1. Western Europe Tepezza Market Overview

    17.2. Western Europe Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Tepezza Market

    18.1. UK Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Tepezza Market

    19.1. Germany Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Tepezza Market

    20.1. France Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Tepezza Market

    21.1. Eastern Europe Tepezza Market Overview

    21.2. Eastern Europe Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Tepezza Market

    22.1. North America Tepezza Market Overview

    22.2. North America Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Tepezza Market

    23.1. USA Tepezza Market Overview

    23.2. USA Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Tepezza Market

    24.1. Canada Tepezza Market Overview

    24.2. Canada Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Tepezza Market

    25.1. South America Tepezza Market Overview

    25.2. South America Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Tepezza Market

    26.1. Middle East Tepezza Market Overview

    26.2. Middle East Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Tepezza Market

    27.1. Africa Tepezza Market Overview

    27.2. Africa Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Tepezza Market Competitive Landscape And Company Profiles

    28.1. Tepezza Market Competitive Landscape

    28.2. Tepezza Market Company Profiles

    28.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

    29. Global Tepezza Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Tepezza Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Tepezza Market

    32. Recent Developments In The Tepezza Market

    33. Tepezza Market High Potential Countries, Segments and Strategies

    33.1 Tepezza Market In 2029 - Countries Offering Most New Opportunities

    33.2 Tepezza Market In 2029 - Segments Offering Most New Opportunities

    33.3 Tepezza Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Tepezza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Tepezza Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Global Tepezza Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: Asia-Pacific, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: China, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: India, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Japan, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: Australia, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: South Korea, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: Western Europe, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: UK, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: Germany, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: France, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: Eastern Europe, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: North America, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: USA, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: Canada, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: South America, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Middle East, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Africa, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 60: Amgen Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Tepezza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Tepezza Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Global Tepezza Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: Asia-Pacific, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: China, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: India, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Japan, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: Australia, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: South Korea, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: Western Europe, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: UK, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: Germany, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: France, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: Eastern Europe, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: North America, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: USA, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: Canada, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: South America, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Middle East, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Tepezza Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Tepezza Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Africa, Tepezza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 60: Amgen Inc. Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Read More

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

Read More

What Is The Compression Therapy Market Overview In 2022?

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the anti-parkinson drugs market research report 2022 with industry size, share, segments and market growth

Read More

Insulin Pens, Syringes, Pumps And Injectors Market - By Type (Pens, Injectors And Pumps, Syringes), By End Users (Hospitals, Homecare), By Pens (Reusable, Disposable), By Pumps (Tubed Pumps, Tubeless Pumps), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Insulin Drugs Market 2022 – By Product Type (Basal Or Long-Acting Insulins, Bolus Or Fast-Acting Insulins, Pre-Mixed, And Intermediate And Short Acting Insulins), By Source Type (Insulin Analogs, Human Insulin), By Application (Type 2 Diabete, Type 1 Diabetes, Gestational Diabetes), By Drug Classification (Branded Drugs, Generic Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) And By Region, Opportunities And Strategies – Global Forecast To 2031

View Report

Insulin Patch Pumps Global Market Report 2025 – By Type (Traditional Insulin Pumps, Smart Insulin Pump, Disposable Insulin Pumps), By Mode (Basal, Bolus), By Pump Type (Tethered Pump, Patch Pump), By Application (Type 1 Diabetes, Type 2 Diabetes), By End-User (Hospital, Clinics, Laboratories, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Insulin biosimilars Global Market Report 2025 – By Biosimilars Type (Rapid Acting biosimilars, Long Acting biosimilars, Premixed Acting biosimilars), By Disease Indication Type (Type I Diabetes, Type II Diabetes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Insulin Drugs Global Market Report 2025 – By Product Type (Basal Or Long-Acting Insulins, Bolus Or Fast-Acting Insulins, Pre-Mixed, And Intermediate And Short Acting Insulins), By Source Type (Insulin Analogs, And Human Insulin), By Drug Classification (Branded Drugs, And Generic Drugs), By Application (Type 2 Diabetes, Type 1 Diabetes, And Gestational Diabetes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Smart Insulin Pens Global Market Report 2025 – By Type (First Generation Pens, Second Generation Pens), By Usability (Prefilled, Reusable), By Application (Type 1 Diabetes, Type 2 Diabetes), By End User (Hospitals & Clinics, Ambulatory Surgical Centres, Home Care Settings) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2025 – By Type (Pens, Injectors And Pumps, Syringes), By Pens (Reusable, Disposable), By Pumps (Tubed Pumps, Tubeless Pumps), By End Users (Hospitals, Homecare, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Smart Insulin Pens Market 2021 - By Type (First Generation Pens, Second Generation Pens (Bluetooth Enabled, USB Connected)), By End User (Hospitals & Clinics, Ambulatory Surgical Centres, Home Care Settings), By Usability (Prefilled, Reusable), By Application (Type 1 Diabetes, Type 2 Diabetes), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the Tepezza market?

Tepezza refers to a prescription medication containing teprotumumab-trbw, a monoclonal antibody designed to target and inhibit the activity of insulin-like growth factor-1 receptor (IGF-1R). It is used for the treatment of thyroid eye disease (TED), a rare autoimmune condition that affects the muscles and tissues around the eyes, causing inflammation, swelling, and vision problems. For further insights on the Tepezza market, request a sample here

How will the Tepezza market drivers and restraints affect the market dynamics? What forces will shape the Tepezza industry going forward?

The Tepezza market major growth driver - Increasing Incidence Of Thyroid Diseases Driving Market Growth. For further insights on the Tepezza market, request a sample here

What is the forecast market size or the forecast market value of the Tepezza market?

The Tepezza market size has grown strongly in recent years. The tepezza market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the increasing prevalence of thyroid eye disease, approval by the FDA for TED treatment, limited treatment options for TED, high unmet need for effective therapies, advancement in biologic drug development, and growing awareness and diagnosis of TED. The tepezza market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to a growing aging population, expansion into new geographical markets, increasing incidence of thyroid diseases, advancements in personalized medicine, and growing adoption of biologic therapies. Major trends in the forecast period include a shift towards home-based care, development of alternative administration methods, rise in combination therapies for TED, increasing focus on precision medicine, and integration of AI in treatment planning. For further insights on the Tepezza market, request a sample here

How is the Tepezza market segmented?

The tepezza market covered in this report is segmented –
1) By Clinical Indication: Thyroid Eye Disease (TED); Orbital Inflammatory Diseases; Inflammatory Ocular Conditions
2) By Route Of Administration: Intravenous; Subcutaneous
3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies
4) By End User: Adult; Geriatric For further insights on the Tepezza market, request a sample here

Which region has the largest share of the Tepezza market? What are the other regions covered in the report?

North America was the largest region in the tepezza market in 2024. The regions covered in the tepezza market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Tepezza market, request a sample here.

Who are the major players in the Tepezza market?

Major companies operating in the tepezza market are Amgen Inc. . For further insights on the Tepezza market, request a sample here.

What are the key trends in the Tepezza market?

Major trends in the Tepezza market include Regulatory Advancements Expand Tepezza’s Accessibility And Impact In Thyroid Eye Disease. For further insights on the Tepezza market, request a sample here.

What are the major opportunities in the Tepezza market? What are the strategies for the Tepezza market?

For detailed insights on the major opportunities and strategies in the Tepezza market, request a sample here.

How does the Tepezza market relate to the overall economy and other similar markets?

For detailed insights on Tepezza's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Tepezza industry?

For detailed insights on the mergers and acquisitions in the Tepezza industry, request a sample here.

What are the key dynamics influencing the Tepezza market growth? SWOT analysis of the Tepezza market.

For detailed insights on the key dynamics influencing the Tepezza market growth and SWOT analysis of the Tepezza industry, request a sample here.